Literature DB >> 3089815

Glucoregulation in acute liver failure.

H Vilstrup, J Iversen, N Tygstrup.   

Abstract

Five patients with fatal acute liver failure, given 5 g h-1 of glucose for the previous 12 h, were investigated by the hyper- and euglycaemic glucose 'clamp' technique, and the results compared with reported control values. Initial average blood glucose concentration was normal (6.0 mmol l-1, range 5.0-8.8). Plasma insulin and C-peptide concentrations were increased about tenfold (1450 pmol l-1, range 330-4021, and 3000 pmol l-1, range 670-7650, respectively). The whole body glucose metabolic rate was decreased to about half control values (21 mumol min-1 kg-1, range 6-28) and the insulin sensitivity of the glucose metabolism was decreased to about 15% (9.4 m3 min-1 kg-1, range 3.6-14.4). The calculated metabolic clearance of insulin was normal (520 ml min-1 (m2)-1, range 305-1027) and the calculated systemic delivery rate of insulin was about sixfold increased (1135 pmol min-1 (m2)-1, range 474-2010). The initial glucagon concentrations were fifty-fold increased (550 pmol 1, range 72-1309) and not suppressible by glucose and insulin. The patients thus exhibited pronounced insulin insensitivity and hyperinsulinaemia, attributable primarily to pancreatic hypersecretion. The reason for the relation between, and the pathogenetic importance of, these findings is not known.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089815     DOI: 10.1111/j.1365-2362.1986.tb01328.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

Review 3.  Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation.

Authors:  Chul Soo Park
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Insulin and glucagon levels in fulminant hepatic failure in man.

Authors:  F Fiaccadori; G Pedretti; C Ferrari; P Pizzaferri; O Riggio; N Orlandi; A Pezzarossa
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 5.  [Nutrition and liver failure].

Authors:  M Plauth
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-05-18       Impact factor: 0.840

6.  Stress burden related to postreperfusion syndrome may aggravate hyperglycemia with insulin resistance during living donor liver transplantation: A propensity score-matching analysis.

Authors:  Sumin Chae; Junghee Choi; Sujin Lim; Ho Joong Choi; Jaesik Park; Sang Hyun Hong; Chul Soo Park; Jong Ho Choi; Min Suk Chae
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

7.  Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Anupamaa Seshadri; Rachel Appelbaum; Samuel P Carmichael; Joseph Cuschieri; Jason Hoth; Krista L Kaups; Lisa Kodadek; Matthew E Kutcher; Abhijit Pathak; Joseph Rappold; Sean R Rudnick; Christopher P Michetti
Journal:  Trauma Surg Acute Care Open       Date:  2022-08-01

Review 8.  Nutrition and Chronic Liver Disease.

Authors:  Rocío Aller de la Fuente
Journal:  Clin Drug Investig       Date:  2022-04-29       Impact factor: 3.580

Review 9.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18

10.  Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.

Authors:  Emilie Glavind; Niels Kristian Aagaard; Henning Grønbæk; Holger Jon Møller; Nikolaj Worm Orntoft; Hendrik Vilstrup; Karen Louise Thomsen
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.